Lv2
156 积分 2025-03-04 加入
YKL-40 derived from infiltrating macrophages cooperates with GDF15 to establish an immune suppressive microenvironment in gallbladder cancer
1天前
待确认
A humanized Anti-YKL-40 antibody inhibits tumor development
1天前
已完结
Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors
2个月前
已完结
Optimizing Early Clinical Investigations in Cancer Immunotherapy: The Translational Journey of RG6292, a Novel, Selective Treg‐Depleting Antibody
2个月前
已完结
A novel PARP-ATR dual inhibitor exhibits anti-triple-negative breast cancer activity by inducing excessive DNA damage in the mitotic phase
2个月前
已完结
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity
3个月前
已关闭
PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
4个月前
已完结
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance
5个月前
已完结
Durable response to an anti-CD25 antibody-drug conjugate and anti-PD-1 antibody in ovarian carcinoma: a case report
5个月前
已完结
Antibody-bottlebrush prodrug conjugates for targeted cancer therapy
6个月前
已完结
皖公网安备34019202002308
